CRISPR technology is transforming modern medicine by enabling precise DNA editing to treat genetic disorders, including sickle cell anemia and beta-thalassemia, experts say.

CRISPR is revolutionizing medicine by enabling precise DNA edits, treating genetic diseases like sickle cell anemia and ...

Editas Medicine, Inc. (NASDAQ:EDIT) ranks among the best CRISPR stocks to buy. At the European Hematology Association 2025 ...

Minister of State, Public Health & Family Welfare, Maharashtra, Meghana Bordikar, said on Thursday that couples may soon need ...

Beta thalassemia intermedia. This is a moderate form of thalassemia. You may need treatment and blood transfusions, so your body has healthy hemoglobin and red blood cells.

Repositioning genes awakens fetal hemoglobin to treat disease. CRISPR editing may change future gene therapy. Researchers ...

In a major advancement for global thalassemia care, the results of a landmark global phase 3 clinical trial of mitapivat in ...

β-thalassemia in the heterozygous state is characterized by significant elevations of hemoglobin A 2 in more than 90 per cent of cases. 2,3 This form of thalassemia "interacts" with abnormal β ...

Meghana Bordikar also informed the House that a probe was underway by the health department commissioner into alleged ...

Ten-month-old little Azharul should have been toddling around the house by now, but instead, he lies on a hospital bed. Since ...

Maharashtra is planning to make thalassemia testing mandatory before marriage, as part of its campaign to eradicate the genetic blood disorder.